FDA authorizes emergency use of Pfizer, BioNTech COVID vaccine to kids 12-15


    The U.S. Food and Drug Administration late Monday authorized the emergency use of Pfizer Inc. PFE, +0.71% and BioNTech SE BNTX, +10.15% COVID-19 vacccine for children between the ages of 12 and 15. Acting FDA commissioner Janet Woodcock called the expansion of the emergency use a “significant step in the fight against the COVID-19 pandemic.” The FDA had granted the vaccine emergency use for people 16 and older. “Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our COVID-19 vaccine emergency use authorizations,” she said. From March 2020 through April 2021, about 1.5 million COVID-19 cases in kids 11 to 17 years of age have been reported to the Centers for Disease Control and Prevention, the FDA said.

    This article was originally published by Marketwatch.com. Read the original article here.

    Previous articleThe Moneyist: My wife’s brother, 60, lives with his mom. He thinks the house belongs to him. What should happen after my mother-in-law dies?
    Next articleFDA OKs use of Pfizer-BioNTech COVID-19 vaccine in kids ages 12 to 15


    Please enter your comment!
    Please enter your name here